Researchers have identified biomarkers that can predict disease progression in multiple sclerosis, which could lead to the ...

Motor neuron diseases are a group of progressive and ultimately fatal neurodegenerative disorders of the motor system, ...

The Phase 1 clinical trial is expected to enroll about 60 participants to test how safe and well tolerated multiple doses of ...

Dr. Tilman explains the functions of iPSC-derived microglia and their relevance to conditions like Alzheimer’s.

Published today in Frontiers in Neuroscience, the study fundamentally alters brain and nervous system medicine-giving doctors new clues as to why patients with motor neuron disease, multiple sclerosis ...

ATH-1105 is an orally delivered, positive modulator of the neurotrophic HGF system that is currently in a Phase 1 clinical ...

Recent innovations, successful trials, and increased research and development spending in the healthcare sector further boost ...

The hallmark of PD is the progressive degeneration of dopaminergic neurons, particularly in the substantia nigra, a region of the brain integral to the nigrostriatal pathway, which plays a crucial ...

The Society for Neuroscience (SfN) will honor seven researchers who have made significant contributions to the advancement of women in neuroscience. The awards will be presented during Neuroscience ...

A study presented at ECTRIMS 2024 has identified critical biomarkers that can predict disability worsening in multiple ...